400431-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Sections 130a (8) and 130c (1) of the Social Code Book V between IKK classic and Outlook Therapeutics Limited for Lytenava

World Biggest Tenders Source

This tender with title 400431-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Sections 130a (8) and 130c (1) of the Social Code Book V between IKK classic and Outlook Therapeutics Limited for Lytenava has been published on Bidding Source portal dated 30 Jun 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

400431-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Sections 130a (8) and 130c (1) of the Social Code Book V between IKK classic and Outlook Therapeutics Limited for Lytenava

Tender Type :

Contract Award

Reference No. :

400431

Country :

Germany

Publish Date :

30 Jun 2025

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

400529- Germany – Pharmaceutical products – Drug discount agreements pursuant to Section 130a, Paragraph 8 of the Social Code Book V within the framework of open-house procedures Germany 398866- Germany – Pharmaceutical products – Pharmaceutical contracts with accession option Germany 412645-Awarded - Germany – Pharmaceutical products – Drug discount agreement pursuant to Section 130c Paragraph 1 SGB V in conjunction with Section 130a Paragraph 8 SGB V for the active ingredient Romosozumab Germany 381285- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient fluorouracil (ATC code: D11AF05). Germany 382655- Germany – Pharmaceutical products – 1/DLII6/PM020 - Arzneimittel - Virostatika Germany 365213-Awarded - Germany – Pharmaceutical products – Award of sterile saline syringes as of 01.07.2025 Germany 359051-Awarded - Germany – Pharmaceutical products – Minirin Parenteral 4µg Inj.lösung Germany 350661- Germany – Pharmaceutical products – 3. Biologics tender Germany 351177-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130c Paragraph 1 SGB V between IKK classic and Abacus Medicine A/S for Skyrizi(R) -- <b>Contract Value: 1,00 EUR</b> Germany 344615- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the option of concluding the agreement within the framework of the so-called open house procedure. Germany

400431-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Sections 130a (8) and 130c (1) of the Social Code Book V between IKK classic and Outlook Therapeutics Limited for Lytenava

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com